These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3103680)

  • 1. Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis.
    Tate KM; Higgins DL; Holmes WE; Winkler ME; Heyneker HL; Vehar GA
    Biochemistry; 1987 Jan; 26(2):338-43. PubMed ID: 3103680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the one-chain to two-chain conversion in tissue plasminogen activator: characterization of mutations at position 275.
    Higgins DL; Lamb MC; Young SL; Powers DB; Anderson S
    Thromb Res; 1990 Feb; 57(4):527-39. PubMed ID: 2139248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage site.
    Boose JA; Kuismanen E; Gerard R; Sambrook J; Gething MJ
    Biochemistry; 1989 Jan; 28(2):635-43. PubMed ID: 2496749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of tissue-type plasminogen activator with substantially enhanced response and selectivity toward fibrin co-factors.
    Strandberg L; Madison EL
    J Biol Chem; 1995 Oct; 270(40):23444-9. PubMed ID: 7559505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416.
    Petersen LC; Boel E; Johannessen M; Foster D
    Biochemistry; 1990 Apr; 29(14):3451-7. PubMed ID: 2112946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin.
    Tachias K; Madison EL
    J Biol Chem; 1995 Aug; 270(31):18319-22. PubMed ID: 7629153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain.
    Burck PJ; Berg DH; Warrick MW; Berg DT; Walls JD; Jaskunas SR; Crisel RM; Weigel B; Vlahos CJ; McClure DB
    J Biol Chem; 1990 Mar; 265(9):5170-7. PubMed ID: 2108167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a hydrophobic exosite on tissue type plasminogen activator that modulates specificity for plasminogen.
    Ke SH; Tachias K; Lamba D; Bode W; Madison EL
    J Biol Chem; 1997 Jan; 272(3):1811-6. PubMed ID: 8999865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
    Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.
    Lijnen HR; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF; Bassel-Duby RS
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of human tissue-type plasminogen activator substituted at the protease cleavage site and glycosylation sites, and truncated at the N- and C-termini.
    Haigwood NL; Mullenbach GT; Moore GK; DesJardin LE; Tabrizi A; Brown-Shimer SL; Stauss H; Stöhr HA; Pâques EP
    Protein Eng; 1989 Aug; 2(8):611-20. PubMed ID: 2510149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
    J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
    Eastman D; Wurm FM; van Reis R; Higgins DL
    Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
    Higgins DL; Vehar GA
    Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.